Buch, Englisch, 738 Seiten, Format (B × H): 198 mm x 268 mm, Gewicht: 1624 g
Reihe: Methods in Molecular Biology
Methods and Protocols
Buch, Englisch, 738 Seiten, Format (B × H): 198 mm x 268 mm, Gewicht: 1624 g
Reihe: Methods in Molecular Biology
ISBN: 978-1-934115-85-5
Verlag: Humana Press
Zielgruppe
Research
Autoren/Hrsg.
Fachgebiete
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Gentherapie
- Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Vorklinische Medizin: Grundlagenfächer Humangenetik
Weitere Infos & Material
Experimental Approaches in Cancer Gene Therapy: Introduction.- The Development of Gene Therapy: From Monogenic Recessive Disorders to Complex Diseases Such as Cancer.- Vectorology for Cancer Gene Therapy.- Designing Adenoviral Vectors for Tumor-Specific Targeting.- Analysis of HSV Oncolytic Virotherapy in Organotypic Cultures.- Use of Minicircle Plasmids for Gene Therapy.- Transposable Elements as Plasmid-Based Vectors for Long-Term Gene Transfer into Tumors.- Designing Plasmid Vectors.- Development of Bacterial Vectors for Tumor-Targeted Gene Therapy.- Nonviral Transfer Technologies in Cancer Gene Therapy.- Electroporative Gene Transfer.- Gene Gun Delivery Systems for Cancer Vaccine Approaches.- Ultrasound-Mediated Gene Transfection.- Nonviral Jet-Injection Technology for Intratumoral In Vivo Gene Transfer of Naked DNA.- Experimental Studies in Cancer Gene Therapy.- Methods for Constructing and Evaluating Antitumor DNA Vaccines.- Immunity of Lentiviral Vector-Modified Dendritic Cells.- Saporin Suicide Gene Therapy.- Using In Vivo Biopanning for the Development of Radiation-Guided Drug Delivery Systems.- Chemosensitization of Tumor Cells: Inactivation of Nuclear Factor-Kappa B Associated with Chemosensitivity in Melanoma Cells After Combination Treatment with E2F-1 and Doxorubicin.- Induction of Tumor Cell Apoptosis by TRAIL Gene Therapy.- Silencing Epidermal Growth Factor Receptor by RNA Interference in Glioma.- Delivery of Phosphorodiamidate Morpholino Antisense Oligomers in Cancer Cells.- Use of RNA Aptamers for the Modulation of Cancer Cell Signaling.- G-Rich Oligonucleotides for Cancer Treatment.- Clinical Approaches in Cancer Gene Therapy - Requirements for Clinical Gene Therapy Trials.- Regulatory Aspects for Translating Gene Therapy Research into the Clinic.- Ethics of Cancer Gene Transfer Clinical Research.- Virus Production for Clinical Gene Therapy.- Production of Plasmid DNA as Pharmaceutical.- Clinical Protocols in Cancer Gene Therapy.- Gene Immunotherapy for Non-Small Cell Lung Cancer.- Gene Therapy for Antitumor Vaccination.- HSV-tk/IL-2 Gene Therapy for Glioblastoma Multiforme.- Construction and Characterization of an Oncolytic HSV Vector Containing a Fusogenic Glycoprotein and Prodrug Activation for Enhanced Local Tumor Control.- Newcastle Disease Virus: A Promising Vector for Viral Therapy, Immune Therapy, and Gene Therapy of Cancer.- Oncolytic Viral Therapy Using Reovirus.- Design and Testing of Novel Oncolytic Vaccinia Strains.- Tumor-Targeted Salmonella typhimurium Overexpressing Cytosine Deaminase: A Novel, Tumor-Selective Therapy.- Chemoprotection by Transfer of Resistance Genes.- Phase I Clinical Trial of Locoregional Administration of the Oncolytic Adenovirus ONYX-015 in Combination with Mitomycin-C, Doxorubicin, and Cisplatin Chemotherapy in Patients with Advanced Sarcomas.